StarZero All shows Try the podcast clipper →

reimbursement

2 statements across 2 episodes · 0 bullish · 0 bearish · 2 people on the record · first statement Jan 17, 2019 by Vas Narasimhan · across every show →

Everything said about reimbursement, oldest first

Jan 17, 2019 neutral
Disclosure
Narasimhan: Novartis considers drug reimbursement early in development, not at launch
“It used to be, we think about reimbursement as we got to launch. Now we're thinking about it really early in development.”
Vas Narasimhan Jan 17, 2019 ▶ 10:35 a16z Podcast | The Science and Business of Innovative Medicines
Jan 17, 2019
Assertion Not checkable as stated
Pande: The commercial hurdle for new drugs is reimbursement, not FDA approval
“In a world where things have gone past clinical trials, but really now the new barrier is not getting past the FDA, the new barrier is reimbursement.”
Vijay Pande Jan 17, 2019 ▶ 19:33 a16z Podcast | Dark Data in Healthcare
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more